TrialJAMA cardiology2018

Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.

Pratyaksh K Srivastava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.